SWM
BSX icon

Salvus Wealth Management’s Boston Scientific BSX Stock Holding History

Salvus Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,291
Closed -$314K – 130
2025
Q4 		$314K Buy
3,291
+238
+8% +$23.3K 0.18% 106
2025
Q3 		$298K Buy
+3,053
New +$316K 0.17% 108

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Salvus Wealth Management's BSX Position: Q1 2026 in Review

Salvus Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,291 shares — an estimated $314K sold.

Salvus Wealth Management first reported a position in BSX in Q3 2025 and held it in 2 quarters. The position peaked at $314K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Salvus Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Salvus Wealth Management sold 3,291 Boston Scientific shares in Q1 2026, an estimated $314K.
  • Salvus Wealth Management first reported a position in Boston Scientific in Q3 2025 and held it in 2 quarters.
  • Salvus Wealth Management's Boston Scientific position peaked at $314K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Salvus Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.